Purpose: The purpose of this study was to obtain preliminary information ab
out the effect of menopause and perimenopause on the course of epilepsy, an
d to determine whether seizure type, use of hormone-replacement therapy (HR
T), or a history of catamenial seizure pattern would influence this course.
Methods: We performed a questionnaire study of women with epilepsy currentl
y in menopause and perimenopause, requesting information regarding the cour
se of their epilepsy and treatment. Statistical analysis was performed by u
sing Pearson chi(2) With 95% confidence limits.
Results. Forty-two menopausal women (ages 41-86 years) responded. Twelve su
bjects reported no change in seizures at menopause, 17 reported a decrease
in seizure frequency, and 13 reported an increase. Sixteen (38%) took synth
etic HRT. Sixteen (38%) additional subjects (having some overlap with the H
RT group) reported having a catamenial seizure pattern before menopause. HR
T was significantly associated with an increase in seizures during perimeno
pause (p = 0.001). A history of catamenial seizure pattern was significantl
y associated with a decrease in seizures at menopause (p = 0.013). Thirty-n
ine perimenopausal women (ages 38-55 years) responded. Nine subjects report
ed no change in seizures at perimenopause, five reported a decrease in seiz
ure frequency, and 25 reported an increase. Fight (15%) subjects took synth
etic HRT, and 28 (72%) reported having a catamenial seizure pattern before
menopause, HRT had no significant effect on seizures; however, a history of
catamenial seizure pattern was significantly associated with an increase i
n seizures at perimenopause (p = 0.02).
Conclusions: These pilot data suggest that synthetic HRT may be associated
with an increase in seizure frequency in menopausal women with epilepsy. A
catamenial seizure pattern may be associated with seizure decrease during m
enopause but with an increase during perimenopause.